• Pharma
  • October 16, 2023
  • 33 views
90% cheaper cancer treatment gets nod, to be offered in 20 hospitals

MUMBAI: An indigenously developed therapy for treatment of relapsed/refractory B-cell lymphomas and leukaemia by an IIT-Bombay spin-off company has received approval from the national regulatory body and will be available…